RxSight (RXST) Return on Capital Employed (2021 - 2026)
RxSight's (RXST) quarterly Return on Capital Employed came in at 19.72% in Q1 2026, down 714.0% YoY from 3.21% in Q1 2025, and down 16.24% on a QoQ basis from 16.97% in Q4 2025.
RxSight (RXST) Return on Capital Employed (2021 - 2026) Analysis & Trends
RxSight (RXST) has 6 years of Return on Capital Employed data on file, last reported at 19.72% in Q1 2026.
- Quarterly Return on Capital Employed fell 714.0% year-over-year to 19.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 19.72% (down 714.0% YoY) and the FY2025 annual result came in at 16.68%, down 26.0% from the prior year.
- Return on Capital Employed slipped to 19.72% in Q1 2026, from 16.97% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 73.28% in Q3 2022 to a low of 60.1% in Q1 2024.
- A 5-year average of 4.72% and a median of 12.77% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed slumped 7862 bps — and 2025, when it jumped 4752 bps.
- Tracing RXST's Return on Capital Employed over 5 years: stood at 0.17% in 2022, then slumped by 27338 bps to 46.57% in 2023, then surged by 73 bps to 12.77% in 2024, then tumbled by 33 bps to 16.97% in 2025, then dropped by 16 bps to 19.72% in 2026.
- The last three Return on Capital Employed figures came in at 19.72% (Q1 2026), 16.97% (Q4 2025), and 15.9% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 12.08% |
| 10 | RxSight | 249.15 Mn | -155.09 Mn | - | -22.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.24% |
| Mar 31, 2026 | -19.72% |
| Dec 31, 2025 | -16.97% |
| Sep 30, 2025 | -15.90% |
| Jun 30, 2025 | -14.65% |
| Mar 31, 2025 | -12.58% |
| Dec 31, 2024 | -12.77% |
| Sep 30, 2024 | -41.18% |
| Jun 30, 2024 | -53.75% |
| Mar 31, 2024 | -60.10% |
| Dec 31, 2023 | -46.57% |
| Sep 30, 2023 | -0.47% |
| Jun 30, 2023 | 15.20% |
| Mar 31, 2023 | 18.52% |
| Dec 31, 2022 | 0.17% |
| Sep 30, 2022 | 73.28% |
| Jun 30, 2022 | 64.98% |
| Mar 31, 2022 | 42.22% |
| Dec 31, 2021 | 42.22% |
| Sep 30, 2021 | 36.11% |